Authors


Joely Kaufman

Latest:

Lowdown on lasers

Power, energy and fluence ... are really just a few of the parameters of a laser.


Maury M. Breecher, Ph.D., M.P.H.

Latest:

The ArteFill advantage: Longevity

San Diego - ArteFill (Artes Medical), the latest federally approved facial filler, offers dermatologists a long lasting alternative, and, although it has come late to the party, it is the only product now approved that has a potential to remain in the face for years, experts say.


Lawrence A. Schacner, M.D

Latest:

Dermoscopy: A useful tool for gauging atypical lesions

Dr. Schachner: Dr. Johr, tell me about your experience with dysplastic nevi and your management of patients with atypical pigmented skin lesions.


Tricia Butler

Latest:

Long-suffering rosacea patient asks, 'Doctors, please listen to your patients'

In his Guest Commentary "Managing rosacea; practitioners discuss trends" (September 2006), Dr. William Baum presents his findings after moderating advisory panels across the country consisting of specialists talking about the many facets of rosacea.


Ellen Meyer Schneider

Latest:

Insights Improve Aging Skin

San Francisco - According to two recent studies, palmitoyl-pentapeptide (pal-KTTKS) may offer improvement in wrinkles and other age-related complaints, without the redness and other side effects associated with retinol-based products.


Leon H. Kircik, MD

Latest:

Frontline Forum Part 3: Challenges and Opportunities to Enhance Psoriasis Management

A panel of experts discusses tailoring treatment to patient needs, supporting patients' mental health, and considering future directions.


Craig N. Burkhart, M.D., M.S.B.S.

Latest:

Benzoyl peroxide and tumorigenesis-Is there a connection?

Although benzoyl peroxide has been available for consumer use for three decades without any major reported side effects, we add a few comments regarding the safety of benzoyl peroxide at this time.


Robert H. Johr, M.D.

Latest:

Dermoscopy: A useful tool for gauging atypical lesions

Dr. Schachner: Dr. Johr, tell me about your experience with dysplastic nevi and your management of patients with atypical pigmented skin lesions.


Richard Essner, M.D.

Latest:

Skin exam still gold standard

It is noble that Mr. Eckley Keach (June 2006) wishes to alleviate the morbidity and mortality from melanoma, but is he on target in stating that the best way to accomplish this is by utilizing photography as a substitute for patient education, careful serial skin exams and biopsies?


Stan Alfred, M.D.

Latest:

Skin exam still gold standard

It is noble that Mr. Eckley Keach (June 2006) wishes to alleviate the morbidity and mortality from melanoma, but is he on target in stating that the best way to accomplish this is by utilizing photography as a substitute for patient education, careful serial skin exams and biopsies?


Madeliene E. Gainers

Latest:

Lowdown on lasers

Power, energy and fluence ... are really just a few of the parameters of a laser.


Maureen Haggerty

Latest:

The agony of eczema

Costs directly associated with AD range from less than $100 to more than $2,000 per patient per year. In the United States alone, AD's direct costs amount to almost $1 billion a year.


Teresa Mcnulty

Latest:

Facing facts & fallacies

Taking a kinder, gentler approach to facial cleansing can help to avoid some self-inflicted woes.


Walter Alexander

Latest:

Melanoma Survival Rate and Vitiligo

Chicago - Among patients receiving a novel immune-based maintenance biotherapy regimen (mBT) for metastatic melanoma, those who developed vitiligo had longer median survival.


Elizabeth W. Woodcock, M.B.A., F.A.C.M.P.E., C.P.C.

Latest:

Avoid personnel problems by putting a dress code policy in place

With all of the talk about the government's EMR stimulus package, new CPT codes, and the impact of the turbulent economy, you wouldn't pick dress codes as a big concern for medical practices. But as the newest generation entering the work force starts filling positions at your dermatology practice, it won't be long before you, too, may need to establish - or update - your practice's dress code.


Wayne Kuznar

Latest:

Detecting melanoma before it becomes invasive

Newly discovered dermoscopy features differentiate melanoma in situ from benign lesions, shows a study in JAMA Dermatology.


Kevin C. Smith

Latest:

Tune in thousands of radio stations over the Net

Considering the wealth of free radio available over the Net, I would not invest in a broadcaster or in a satellite provider such as XM Radio.


Ilya Petrou, M.D

Latest:

Biologic risk tolerance differs for pregnant patients

Of several biologic agents that women of reproductive age can choose from to treat and manage psoriasis, not all have the same safety profile during pregnancy and lactation periods.


Elizabeth W. Woodcock

Latest:

Electronic health record donations now acceptable

A hospital may provide your practice a qualifying EHR or e-prescribing system and forego - or donate - up to 85 percent of the system's cost.


Ronald G. Wheeland, M.D.

Latest:

A basic primer on vitiligo

Vitiligo affects 3 million people of all skin types per year in the U.S. In this article, Dr. Wheeland summarizes the latest updates on vitiligo, highligting promising treatments to come.


William J. Lynott

Latest:

Cost of living: Plan financial future with long-term inflation in mind

Political considerations aside, President Obama's fiscal policies are likely to serve eventually as a stimulant to growth in our economy. That's why I believe that it's time to take the likelihood of long-term inflation into account as you plan your financial future.


Bill Lynott

Latest:

Old dog, new tricks

ETFs can actually be traded on an intraday basis, impossible with most conventional funds.


Paula Moyer

Latest:

Derms may be first to spot cardiovascular risk in psoriasis patients

People who live with psoriasis have a higher risk of death from cardiovascular disease.


Liz Meszaros

Latest:

Softer Implants

San Francisco - As facial implants come of age, aging faces look even younger. UltraSoft implants are part of the next generation of ePTFE facial implants designed to be softer, with a wider diameter than their predecessor, the SoftForm implant. Manufactured by Tissue Technologies Inc., San Francisco, the permanent facial implants offer dermatologic surgeons an alternative to injectable or temporary fillers for nasolabial folds or lip augmentation that Nicholas Lowe, M.D., FRCP, believes is safer and more effective.


Tricia Hyland Krizner

Latest:

Marketing M.D.s

Jason Myers, D.O., and Lorah Wright, D.O., left a large, hospital-affiliated practice in Traverse City, Mich., to form their own family practice. Recognizing a growing market for cosmetic procedures, the enterprising doctors added a laser skin clinic with the hope of fattening the bottom line. J.P. Huntington and his wife,


Bill Gillette

Latest:

Pioneer skin researcher dies

Richard Winkelmann, M.D., a physician and pioneering dermatology and pathology researcher at the Mayo Clinic, died of pancreatic cancer at his home in Rochester recently. He was 88.


Barbara J. Rutledge, Ph.D.

Latest:

Target four-to-eight-week tx window to minimize formation of scar tissue

To minimize scar formation, intercept facial wounds as early as possible, and treat them during the four-to-eight-week window after the trauma or incision, advises Joseph Niamtu III, D.M.D., an oral/maxillofacial and cosmetic facial surgeon based in Richmond, Va.


Neil Baum, M.D., M.Sc.

Latest:

PDAs plug efficiency into your daily practice

Personal digital assistants (PDAs), have now reached critical mass, and nearly 25 percent of physicians use them on a daily basis. If you haven't implemented this technology into your daily professional life, you might want to consider what these incredible electronic boxes can do for you and your practice. Now it is possible to have all of these functions included in a 3-inch by 5-inch PDA that fits into your pocket. There are software companies that offer more clinical and management PDA applications than most of us realize are available.


Lawrence M. Prescott, Ph.D.

Latest:

5-Fluorouracil Combo Promising

Chicago - The combination of oxaliplatin (Eloxatin) and a continuous infusion of 5-fluorouracil (5-FU) appears to offer a promising chemotherapeutic alternative to the presently administered cisplatin or carboplatin-based approach for the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck, Marc Debled, M.D., said at the American Society of Clinical Oncology meeting.


Naomi Pfeiffer

Latest:

Staphylococcus Aureus Virulence

San Diego - Ominous episodes of furunculosis due to an unusual strain of methicillin-resistant Staphylococcus aureus (MRSA) appeared suddenly among a classroom of third-grade students in a Swiss village. Some boils were so severe and painful the children had to be hospitalized for surgical drainage and IV antibiotics, a Swiss/French research team reported at the recent Interscience Conference on Antimicrobial Agents and Chemotherapy.

© 2024 MJH Life Sciences

All rights reserved.